Gao C, Sun W, Christofidou-Solomidou M, Sawada M, Newman DK, Bergom C, Albelda SM, Matsuyama S, Newman PJ. PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood 102:169-179, 2003.
Maas M, Stapleton M, Bergom C, Mattson DL, Newman DK, Newman PJ. Endothelial cell PECAM-1 confers protection against endotoxic shock. AJP Heart Circ Physiol 288:159-64, 2005.
Bergom C, Gao C, Newman PJ. Mechanisms of PECAM-1-mediated cytoprotection and implications for cancer cell survival. Leuk Lymphoma 46:1409-1421, 2005. Review.
Bergom C, Goel R, Paddock C, Gao C, Newman DK, Matsuyama S, Newman PJ. The cell-adhesion and signaling molecule PECAM-1 is a molecular mediator of resistance to genotoxic chemotherapy. Cancer Biol Ther 5:1699-1707, 2006.
Bergom C, Paddock C, Gao C, Holyst T, Newman DK, Newman PJ. An alternatively spliced PECAM-1 isoform is expressed at high levels in human and murine tissues and reveals a novel role for the C-terminus of PECAM-1 in cytoprotective signaling. J Cell Sci 121:1235-1242, 2008.
Bergom C, Kelly T, Wagner J, Morrow N, Wilson JF, White J. Prone whole breast irradiation using 3-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent-good cosmetic outcomes in patients with large-pendulous breasts. Int J Rad Biol Phys, 83:821-828, 2012.
Bergom C, Kainz K, Morrow N, Ahunbay E, Prior R, White J. Partial breast irradiation (PBI) in the prone position using image-guided IMRT: Preliminary results from a phase II study. Radiother Oncol. 2013 Aug;108(2):215-9.
Hauser AD, Bergom C, Schuld N, Lorimer EL, Li R, Mackinnon AC, Williams CL. The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA activation in breast cancer. Mol Cancer Res. 2014 Jan;12(1):130-42.